Aptima® HPV Assay, powered by mRNA technology, improves specificity, with 24-40% fewer false positives than DNA-based tests. Dr. Kyle Bukowski explains how this can reduce repeat visits, support targeted care and lower reliance on colposcopy.
Watch: ow.ly/g79h50ZiKZG
Watch: ow.ly/g79h50ZiKZG